The Vice President, Data Management, Chief Data Scientis will lead the strategy, build-out, and execution of clinical data management across the company’s clinical development portfolio, with direct responsibility for ensuring that data supporting the company’s marketing authorization applications globally are complete, accurate, consistent, and submission-ready. Unwavering in our commitment to scientific excellence, Prilenia is developing pridopidine, a potent and selective sigma-1 receptor (S1R) agonist investigational therapy, which stimulates key neuroprotective mechanisms impaired in neurodegenerative diseases such as ALS and Huntington’s disease (HD).